News from d-pharm ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:YEWB,OTC-BB:YEWB.OB)

May 19, 2015, 05:00 ET
The World's Largest Healthcare Event -- tHIS Opens to Record Breaking Crowds

The World's Largest Healthcare Event -- tHIS Opens to Record Breaking Crowds in Shanghai

The 2015 Health Industry Summit (tHIS), an event that is predicted to transform the Chinese healthcare industry sector, opened to huge crowds on...

May 14, 2015, 16:00 ET

Yew Bio-Pharm Group Reports 2015 First Quarter Financial Results

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of...

May 14, 2015, 08:00 ET

D-Pharm Receives Final Report for Its Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With tPA

D-Pharm Ltd. (TASE: DPRM) reported today, May 14th, 2015, that it has received the final report for its Phase 2 clinical study of THR-18. THR-18...

May 11, 2015, 08:00 ET

Yew Bio-Pharm Group Signs the Tripartite Joint Planting Auricularia Auricula Contract and Acquires Financial Supporting from BOCOM

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (YEWB), a major grower and seller of yew trees and yew raw materials used in the manufacture...

Apr 14, 2015, 08:00 ET

C-FDA Approves IND for D-Pharm's Anti-Epileptic Drug, DP-VPA in China

D-Pharm Ltd., (TASE: DPRM) has been notified by its co-development partner, Jiangsu Nhwa Pharmaceutical Co., Ltd. (Nhwa), that they received an...

Apr 01, 2015, 06:00 ET

Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Mar 23, 2015, 08:00 ET

Yew Bio-Pharm Group Signs Sales Agreement and Receives Subsidy Grant from the Finance Department of Heilongjiang Province, China

 Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (YEWB) a major grower and seller of yew trees, yew raw materials used in the...

Jan 21, 2015, 09:44 ET

D-Pharm Succeeds to Raise 12.8M NIS in Rights Offering

D-Pharm Ltd (TASE: DPRM) announced today 21st January, 2015, successful completion of fundraising via a public rights issue, of 12.8M NIS in...

Dec 18, 2014, 08:00 ET

D-Pharm Achieves Primary End-point in Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With tPA

D-Pharm Ltd. (TASE: DPRM) reported today, December 18th, 2014, that its Phase 2 clinical study of THR-18 successfully achieved its primary...

Dec 16, 2014, 08:00 ET

Yew Bio-Pharm to Enter U.S. Health Supplement Market With Two New Agaric Polysaccharide Products Focused on Enhancing Immunity

 Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), today announced that it is entering into the U.S. health supplement...

Nov 17, 2014, 09:30 ET

Yew Bio-Pharm Group Reports Improved Financial Results For 2014 Third Quarter

 Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Nov 04, 2014, 09:30 ET

Yew Bio-Pharm Establishes New Subsidiary to Focus on Organic Foods and Functional Beverages

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), today announced the creation of a new subsidiary, Harbin Yew Food Co. LTD.,...

Nov 04, 2014, 08:51 ET

D-Pharm Reports First Results From its Phase 2 Clinical Study of THR-18 In Acute Stroke Patients Treated with tPA

D-Pharm Ltd (TASE: DPRM) reported today, November 4th, 2014, top-line safety results following completion of its Phase 2 clinical study of THR-18...

Oct 30, 2014, 09:30 ET

Yew Bio-Pharm Applauds China State Forestry Administration's Creation of Subsidies to Encourage Chinese Medicinal Herb Crops

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Oct 15, 2014, 02:32 ET

ScinoPharm Recognized as API Supplier of the Year at Global Generics & Biosimilars Awards

ScinoPharm (TWSE:1789) announced that it was named the "Active Pharmaceutical Ingredient (API) Supplier of the Year" at the Global Generics and...

Oct 13, 2014, 08:05 ET

Yew Bio-Pharm Signs Exclusive Distribution Agreement with Carpal Aid to Market Carpal Tunnel Syndrome Product in China

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Aug 14, 2014, 16:05 ET

Yew Bio-Pharm Group Reports 2014 Second Quarter Financial Results

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Jul 15, 2014, 08:00 ET

Yew Bio-Pharm Welcomes Two New Board Members

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Jun 12, 2014, 08:00 ET

D-Pharm's DP-b99 Prevents Abnormal Neuronal Plasticity and Pathological Brain Reorganization

D-Pharm Ltd. (TASE: DPRM) announced today, publication in PLOS ONE, of promising results from a study of its drug candidate DP-b99. The findings...

Jun 02, 2014, 08:00 ET

D-Pharm Reports Completion of the Second Dose Tier in its Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated with the Thrombolytic Drug tPA

D-Pharm Ltd. (TASE: DPRM), Rehovot, Israel, reports today, June 2nd, 2014, the interim results for the second dose tier of stroke patients that...